Stacy Lindborg Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Stacy Lindborg is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 48,229 shares of BCLI, which is worth approximately $107,550. The most recent transaction as insider was on Jan 01, 2025, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.2K
88.61% 3M change
73.43% 12M change
Total Value Held $107,550

Stacy Lindborg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2025
BUY
Grant, award, or other acquisition
-
20,000 Added 29.31%
48,229 Common Stock
Mar 11 2024
BUY
Grant, award, or other acquisition
-
241,935 Added 36.36%
423,435 Common Stock
Sep 01 2023
BUY
Open market or private purchase
$20,355 $1.77 p/Share
11,500 Added 5.96%
181,500 Common Stock
Aug 02 2023
BUY
Grant, award, or other acquisition
-
35,000 Added 17.07%
170,000 Common Stock
Apr 20 2023
BUY
Grant, award, or other acquisition
-
75,000 Added 35.71%
135,000 Common Stock
Dec 07 2022
BUY
Grant, award, or other acquisition
-
35,000 Added 36.84%
60,000 Common Stock

Also insider at

CLSN
Celsion CORP Healthcare
President and CEO
SL

Stacy Lindborg

Director
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI